I et ikke- sammenlignende studie fik 235 patienter med genotype 1 og lav virusmængde (< 600. 000 IE/ ml) peginterferon alfa- 2b 1, 5 mikrogram/ kg subkutant en gang ugentlig i kombination med vægtjusteret Rebetol.
In a non-comparative trial, 235 patients with genotype 1 and low viral load (< 600,000 IU/ml) received peginterferon alfa-2b, 1.5 microgram/kg subcutaneously, once weekly, in combination with weight adjusted Rebetol.